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Abstract
Neutralizing antibodies against West Nile (WNV) and Usutu
(USUV) viruses were measured in 6000 samples collected, between
1 September 2010 and 30 June 2011, from blood donors living in
different districts of Emilia-Romagna, northeastern Italy. On the
basis of the microneutralization assay (MNTA), 47 (0.78%) subjects
were positive for WNV and 14 (0.23%) for USUV. These results
were compared with those obtained 2 years ago and suggest an
increased circulation of USUV among humans in Emilia-Romagna.
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Introduction
Usutu (USUV) and West Nile (WNV) viruses belong to the
family Flaviviridae and are transmitted by mosquitoes, mainly of
the genus Culex [1].
While the risk represented by WNV infection for human
health is well recognized, the medical importance of USUV is
not yet fully understood. WNV has circulated in Europe since
the 1960s [2–4] and in Italy the ﬁrst human case of WNV
neuroinvasive infection was reported in 2008 [5].
Up to 2009, when the ﬁrst two neurological cases of human
USUV infection were reported in Italy [6,7], this virus was
mainly associated with disease in birds [8]. Speciﬁc antibody
responses against USUV were recently identiﬁed among
healthy blood donors (BDs) in Italy [9] and in Germany [10].
These ﬁndings suggest that USUV is likely to be able to
generate a systemic antibody response following asymptomatic
infection in humans.
After the ﬁrst reported cases of human WNV-related
disease, a serosurvey study for the identiﬁcation of anti-WNV
antibodies among BDs was planned in northeast Italy from 1
October 2008 to 30 September 2009, demonstrating a
seroprevalence of 0.69% [11]. No sample showed neutralizing
speciﬁc titre antibodies for USUV in this previous study.
These results are in agreement with the data regarding the
circulation of WNV and USUV in mosquitoes and in birds in
the same geographical area during the matching period
[12,13].
In the present study the seroprevalence for WNV and
USUV among BDs in Emilia-Romagna was investigated 2 years
after the ﬁrst study. The evaluation was performed from 1
September 2010 to 30 June 2011 and involved the districts in
the Central-Eastern part of the region (Modena, Bologna,
Ferrara, Ravenna, Forlı-Cesena and Rimini). The aim was to
investigate the possible change in the seroprevalence ratio
against WNV and USUV from 2008–2009 to 2010–2011,
comparing two populations of BDs with similar demographic
characteristics [11]. This hypothesis was based on the
surveillance data provided by the integrated regional system
[12–14].
The study cohort included 6000 healthy adult volunteer
BDs. Serum samples were collected from all consecutive blood
donations from each BD over the study period: once a subject
was found positive for WNV antibodies, he/she was not
examined further. Written informed consent was obtained
from each BD before sampling. All samples were analyzed as
previously described [11,15].
One hundred and twenty-ﬁve BDs (mean age 45.6 years,
range 20–63, male:female ratio 4.4) out of the total evaluated
were positive for IgG against WNV by the screening methods,
whereas no sample resulted in positive IgM. The IgG-positive
samples had a titre ranging from 1/100 to 1/6400, although the
most frequent values ranged from 1/100 to 1/400. The IgG
avidity was high (>40%) in 117 samples and low (<40%) in the
remaining eight specimens (Table 1).
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The presence of WNV-speciﬁc antibodies was conﬁrmed in
47 samples by MNTA (Fig. 1); 15 of these specimens had a
WNV only neutralizing the immune response.
Neutralizing antibodies against USUV were identiﬁed in 14
samples (Fig. 1; Table 2), one of which showed neutralizing
activity only for USUV.
In the remaining 64 samples that tested positive by the
screening assay, it was impossible to establish a speciﬁc
neutralizing titre: 11 samples had the same neutralizing titre
both for WNV and USUV; 53 samples were deﬁned as
indeterminate (i.e. the difference between the virus-speciﬁc
neutralizing immune responses was lower than four times).
Based on the screening results, the WNV seroprevalence
was 2.08%; tested sera included in this percentage contained
antibodies capable of neutralizing both WNV and USUV.
Considering the MNTA ﬁndings, the WNV seroprevalence
was 0.78%, being 0.23% for USUV.
In order to compare the results of the present (2010–2011)
and the previous (2008–2009, involving only BDs from the area
of Ferrara [11]) studies, we paralleled the results obtained only
among the BDs living in the district of Ferrara (42 MNTA
positive out of the total of 125 in the present study). Twenty-
two showed a speciﬁc neutralizing titre for WNV (Fig. 1), two
showed a speciﬁc neutralizing titre for USUV (Fig. 1), and for
18 the neutralizing activity remained not virus speciﬁc.
The previous study carried out in 2008–2009 reported a
seroprevalence of 0.69% for WNV and no samples showed
speciﬁc neutralizing antibodies for USUV [11]. The data
presented here showed that in the more recent period
(2010–2011) the population of healthy BDs developed neu-
tralizing antibodies speciﬁc for USUV [10]. On the basis of the
MNTA ﬁndings obtained in this evaluation, the seroprevalence
was 0.78% and 0.23% for WNV and USUV, respectively.
While the seroprevalence obtained for WNV is very similar
to the one obtained in the 2008–2009 study [11], the USUV-
speciﬁc seroprevalence is a new ﬁnding.
The results of the present study showed an elevated
percentage of samples with quite low titre against WNV. This
is probably due to WNV infections that were not recently
acquired but probably acquired during the ﬁrst appearance of
WNV in the area in the 2008–2009 season. This hypothesis is
also corroborated by the results of the avidity testing, which
showed an elevated avidity for 117/125 samples. The MNTA
results for the eight samples with low avidity demonstrated a
USUV-speciﬁc neutralizing activity in three of these specimens
(Table 1).
TABLE 1. Detail about the anti-WNV-positive blood donors with low avidity IgG
Sample
number
District of
residence
IgG-WNV IFA
antibody titres
IgM-WNV IFA
antibody titres MNTA titre
IgG-WNV
avidity (%)
1 Modena 1/200 Neg 1/10a 39
2 Modena 1/100 Neg  1:640b 38
3 Bologna 1/800 Neg Indeterminatec 40
4 Bologna 1/400 Neg Indeterminatec 27
5 Bologna 1/200 Neg 1:320b 15
6 Ferrara 1/200 Neg 1:80b 32
7 Modena 1/400 Neg Indeterminatec 38
8 Modena 1/100 Neg Indeterminatec 17
MNTA, microneutralization assay; WNV, West Nile virus; IFA, immunoﬂuorescence assay.
aSamples with the same MNTA titre against WNV and USUV.
bSamples with speciﬁc MNTA titre against USUV.
cSamples that do not show a speciﬁc MNTA titre for either WNV or USUV.
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Emilia FIG. 1. Map of the Emilia-Romagna
region showing the number of blood
donors detected positive by MNTA for
West Nile (triangle) and Usutu (circle)
virus-speciﬁc antibody by province.
Please note that in this study only six
provinces (Modena, Bologna, Ferrara,
Ravenna, Forli-Cesena and Rimini) were
studied.
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The high percentage of samples with non-virus-speciﬁc
neutralizing antibodies found in this study may be due to the
fact that individuals previously infected with WNV could
have subsequently acquired an asymptomatic USUV infec-
tion.
In our view, the interesting fact highlighted by this study is
the determination, for the ﬁrst time, of a percentage of
seroprevalence for USUV in a large number of healthy
subjects. The possibility that the recent spreading of USUV
in the Italian population is due to evolutionary divergence of a
human-speciﬁc virus is under evaluation. Additionally, the
seroprevalence data obtained in this study can be used to
generate a valuable index of the risk of viral infection for the
population living in areas where USUV is spreading. Moreover,
the results of this study showed a co-circulation of WNV and
USUV in the study area and corroborated the hypothesis
regarding USUV infection among humans. These ﬁndings, and
the recent report of a USUV-speciﬁc antibody response
among BDs in Germany [10], emphasize the need for
monitoring the circulation of both viruses in selected
geographical areas.
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TABLE 2. Summary of the characteristics of the 14 blood donors with a USUV-speciﬁc antibody response
Sample
number
District of
residence
IFA IgG-WNV
antibody titres
IFA IgM-WNV
antibody titres
USUVMNT
A titre
WNV IgG
avidity (%)
1 Modena 1/100 Neg  1:640 38
2 Bologna 1/100 Neg  1:640 46
3 Modena 1/200 Neg  1:640 42
4 Bologna 1/100 Neg 1/320 48
5 Ravenna 1/100 Neg 1/320 77
6 Bologna 1/100 Neg 1/80 86
7 Bologna 1/100 Neg  1:640 49
8 Ferrara 1/200 Neg 1/80 32
9 Modena 1/200 Neg 1/80 79
10 Modena 1/100 Neg 1/80 51
11 Bologna 1/100 Neg 1/80 68
12 Ferrara 1/200 Neg 1/320 86
13 Bologna 1/200 Neg 1/160 99
14 Bologna 1/200 Neg 1/320 15
MNTA, microneutralization assay; IFA, immunoﬂuorescence assay; WNV, West Nile virus; USUV, Usutu virus.
ª2013 The Authors
Clinical Microbiology and Infection ª2013 European Society of Clinical Microbiology and Infectious Diseases, CMI, 19, E451–E453
CMI Pierro et al. Seroprevalence of West Nile and Usutu viruses in Italy E453
